Quent Capital’s Insmed INSM Stock Holding History

Quent Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Buy	616 +573	+1,333%	+$88.1K	0.01%	545
2025 Q4	$7.48K	Buy	43 +17	+65%	+$3.1K	﹤0.01%	1206
2025 Q3	$3.74K	Buy	+26	New	+$3.19K	﹤0.01%	1189

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quent Capital's INSM Position: Q1 2026 in Review

Quent Capital increased its Insmed (INSM) stake by 1,333% in Q1 2026, buying an estimated $88.1K and bringing the position to 616 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #545.

Quent Capital first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Quent Capital held 616 shares of Insmed worth $101K as of Q1 2026.
Quent Capital bought 573 Insmed shares in Q1 2026, an estimated $88.1K.
Insmed made up 0.01% of Quent Capital's portfolio in Q1 2026, its #545 holding.
Quent Capital first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.